| Bradley Ray Plant, DPT, CSCS | |
|
1219 Tulip Ln, Missoula, MT 59802-3048 | |
| (406) 240-8458 | |
| Not Available |
| Full Name | Bradley Ray Plant |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 1219 Tulip Ln, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023322377 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 06299 (Oregon) | Primary |
| Provider Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Stroke, heart attacks and numerous other common disorders result in a massive destruction of cells and tissues called necrosis. It's a violent event: As each cell dies, its membrane ruptures, releasing substances that trigger inflammation, which in turn can cause more cellular necrosis.
A new type of therapeutic food, specifically designed to repair the gut microbiomes of malnourished children, is superior to standard therapy in an initial clinical trial conducted in Bangladesh.
Traditionally, the theory driving discussions on the high cost of health care in the United States has been that there is enormous waste in the system, taking the form of excess utilization of care. From that theory it follows that methods of controlling the growth of health spending should focus on ways to reduce the use of unnecessary or only marginally beneficial health care.
Dendreon Corporation today announced that it has completed the submission of the amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T), the Company's lead investigational product, to the U.S. Food and Drug Administration (FDA). Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice entered into a Deferred Prosecution Agreement filed today with the United States District Court in the Western District of Texas (the Court).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley Ray Plant, DPT, CSCS 1219 Tulip Ln, Missoula, MT 59802-3048 Ph: (406) 240-8458 | Bradley Ray Plant, DPT, CSCS 1219 Tulip Ln, Missoula, MT 59802-3048 Ph: (406) 240-8458 |
News Archive
Stroke, heart attacks and numerous other common disorders result in a massive destruction of cells and tissues called necrosis. It's a violent event: As each cell dies, its membrane ruptures, releasing substances that trigger inflammation, which in turn can cause more cellular necrosis.
A new type of therapeutic food, specifically designed to repair the gut microbiomes of malnourished children, is superior to standard therapy in an initial clinical trial conducted in Bangladesh.
Traditionally, the theory driving discussions on the high cost of health care in the United States has been that there is enormous waste in the system, taking the form of excess utilization of care. From that theory it follows that methods of controlling the growth of health spending should focus on ways to reduce the use of unnecessary or only marginally beneficial health care.
Dendreon Corporation today announced that it has completed the submission of the amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T), the Company's lead investigational product, to the U.S. Food and Drug Administration (FDA). Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice entered into a Deferred Prosecution Agreement filed today with the United States District Court in the Western District of Texas (the Court).
› Verified 5 days ago
Shelley Clark, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2803 Rockridge Ct Apt 5, Missoula, MT 59808 Phone: 605-661-0879 | |
Rachael Herynk, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1705 Bow St, Missoula, MT 59801 Phone: 406-549-5283 Fax: 406-549-5392 | |
Rhonda Wakai, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1940 Harve Ave, #2, Missoula, MT 59801 Phone: 406-542-0808 Fax: 406-542-0909 | |
Dr. Matthew Schumacher, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2360 Mullan Rd Ste C, Missoula, MT 59808 Phone: 406-721-4436 | |
Mr. John Fiore, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2207 S 3rd St W, Missoula, MT 59801 Phone: 406-549-5283 Fax: 406-549-5392 | |
Jennifer K Helmer, MSPT, CHT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2740 South Ave W Ste 101, Missoula, MT 59804 Phone: 406-543-0617 Fax: 406-728-1085 | |
Catherine B Gilbert, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 |